Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV001326738 | SCV001517783 | uncertain significance | Bardet-Biedl syndrome 3; Retinitis pigmentosa 55 | 2022-06-17 | criteria provided, single submitter | clinical testing | This sequence change replaces aspartic acid, which is acidic and polar, with asparagine, which is neutral and polar, at codon 110 of the ARL6 protein (p.Asp110Asn). This variant is present in population databases (rs200100002, gnomAD 0.003%). This variant has not been reported in the literature in individuals affected with ARL6-related conditions. ClinVar contains an entry for this variant (Variation ID: 1026308). Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Prevention |
RCV003399110 | SCV004106049 | uncertain significance | ARL6-related condition | 2023-04-10 | criteria provided, single submitter | clinical testing | The ARL6 c.328G>A variant is predicted to result in the amino acid substitution p.Asp110Asn. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.0029% of alleles in individuals of Latino descent in gnomAD (http://gnomad.broadinstitute.org/variant/3-97503872-G-A). At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. |
Dept Of Ophthalmology, |
RCV003888028 | SCV004705581 | uncertain significance | Retinal dystrophy | 2023-10-01 | criteria provided, single submitter | research |